Collaborative for Healthy Rural America™ (CHRA) Launches to Transform Rural Healthcare Nationwide
New coalition of innovators – including Lumeris, Teladoc Health, Nuna, Deloitte, and Unite Us– mobilizes to bring connected, sustainable care...
Day: November 3, 2025
Partillion Launches Developer Kits, Powering Customer-Led Innovation on Nanovials
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- Partillion Bioscience today announced the launch of Developer Kits, a ready foundation for...
LOGICSOURCE TO HELP REDUCE NON-CLINICAL EXPENDITURES
WESTPORT, Conn., Nov. 3, 2025 /PRNewswire/ -- LogicSource, the leading provider of procurement services and technology, is pleased to announce...
Sitero Acquires StudyOS and Launches SiteroAI, Becoming the Industry’s First Truly AI-Powered CRO
MIAMI, Nov. 3, 2025 /PRNewswire/ -- Sitero, a technology-enabled Clinical Research Organization (CRO), today announced it has acquired the AI...
e123 Launches Abacus® — The Growth Engine for Health Plan Sales Distribution
LAGUNA HILLS, Calif., Nov. 3, 2025 /PRNewswire/ -- e123, the leading health insurance distribution management platform, announces the launch of...
MobileX to Provide Free Wireless Service for Customers Who Lost SNAP Benefits
Independent Wireless Carrier Steps in to Keep Americans Connected for as Long as Federal Food Assistance Remains Suspended IRVINE, Calif.,...
Reprieve House Opens Silicon Valley’s First Premium Detox Facility
LOS ALTOS HILLS, CA / ACCESS Newswire / November 3, 2025 / Reprieve House has opened its doors as Silicon...
Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3,...
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and...
“Prejuvenation” Surge: Dr. Shervin Naderi Reveals How Millennials and Gen X Are Delaying Aging – Without Surgery
Dr. Naderi reveals how younger generations are embracing prejuvenation with collagen-boosting treatments and skincare to maintain a natural, youthful glow...
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Key Highlights:Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026...
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a...
Hoggan Scientific Extends Free Warranty Coverage From One Year to Three Years to Thank Customers
Company Extending Warranty as a Promise of Quality and a Thank You to Customers. SALT LAKE CITY, UTAH / ACCESS...
Flash Survey: Hospital IT Ops Leaders Name 2026 Must-Dos Across Tight, Flat, and Growth Budgets
Operators highlight practical levers to speed AI, interoperability, and cyber resilience SAN ANTONIO, TX / ACCESS Newswire / November 3,...
Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has...
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
OCALA, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that...
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
- Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma,...
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the...